Collaborations & Alliances

PAREXEL, Osaka Cancer Institute Form Clinical Alliance in Japan

Aims to drive greater efficiencies in support of clinical trials in oncology and hematology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL and Osaka International Cancer Institute have formed an alliance to advance clinical development in Japan. The partnership aims to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and hematology, to help accelerate the development of new cancer treatments. “Oncology continues to be the largest therapeutic area in clinical trials today, and is a priority for PAREXEL as we partner with clients to deliver new therapies to patients in need,” sai...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters